BioDerm, a portfolio company of Mountaingate Capital, has acquired Argentum Medical, a provider of infection prevention services and wound care products, from Shore Capital Partners.

Based in Geneva, Ill., Argentum offers infection prevention services for the management of wounds. The company manufactures Silverlon, a silver-plated nylon dressing with antimicrobial properties. Argentum’s other product lines include surgical, burn care, negative wound pressure therapy, dressings for IVs and catheters and antimicrobial skin and wound cleansers.

Moelis & Company served as financial advisor to Argentum and Winston & Strawn served as legal advisor to Shore and Argentum.